MetricSide LogoMetricSide
Learn
  1. Home
  2. Stocks
  3. Healthcare
  4. STE

STERIS plcSTE

NYSE•Healthcare•Medical Devices
OverviewPricesGrowthEfficiencyValuationBalanceCash & CapitalAll
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

© 2026 MetricSide. All rights reserved. Data provided for informational purposes only.

STE Revenue & Earnings Growth

Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.

TTM Revenue
$5.94B
8.7%
TTM EBITDA
$1.83B
15.7%
TTM Net Income
$782.30M
27.3%
Q Revenue
$1.59B
7.3%

Analysis

TTM revenue reached $5.94B, growing 8.7% year-over-year. TTM net income stood at $782.30M (27.3% growth). Quarterly EBITDA was $683.90M and operating income was $316.80M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze STE growth trends across revenue, EBITDA, operating income, and net income.

Growth

Revenue and earnings growth across quarters

TTM Revenue
Trailing twelve months revenue
Quarterly Revenue
Single quarter revenue
TTM EBITDA
Trailing twelve months EBITDA
Quarterly EBITDA
Single quarter EBITDA
Operating Income
Single quarter operating income
TTM Net Income
Trailing twelve months profit
Quarterly Net Income
Single quarter profit